Top

Current Nutrition Reports

Published in:

Open Access 01-12-2018 | Diabetes and Obesity (MC de Oliveira Otto, Section Editor)

Dietary Fat and Risk for Type 2 Diabetes: a Review of Recent Research

Author: Beth H. Rice Bradley

Published in: Current Nutrition Reports | Issue 4/2018

Abstract

Purpose of Review

It is estimated that over 400 million people worldwide are living with diabetes. Excess adiposity is the strongest risk factor for non-insulin-dependent diabetes, type 2. Lifestyle interventions have demonstrated that diet plays a critical role in preventing the onset of type 2 diabetes. Dietary fat is not only a source of energy and nutrients, but also bioactive fatty acids.

The purpose of this review was to examine data from recent prospective cohort studies and dietary interventions to determine if there are benefits to fat consumption on diabetes risk.

Recent Findings

The consumption of fish and marine n-3 fatty acids among Asian populations and regular-fat dairy foods and trans-palmitoleic acid (trans-16, n-7) among Western populations may be associated with reduced risk for type 2 diabetes.

Summary

Whereas some dietary fat may contribute to reduced diabetes risk, lifestyle recommendations to balance calories with physical activity are prudent at this time.

Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. https://doi.org/10.1016/j.diabres.2017.03.024.CrossRefPubMed

Hu FB, van Dam RM, Liu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia. 2001;44(7):805–17. https://doi.org/10.1007/s001250100547.CrossRefPubMed

Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. 2014;383(9933):1999–2007. https://doi.org/10.1016/S0140-6736(14)60613-9.CrossRefPubMedPubMedCentral

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. https://doi.org/10.1056/NEJMoa012512.CrossRefPubMed

Via MA, Mechanick JI. Nutrition in type 2 diabetes and the metabolic syndrome. Med Clin North Am. 2016;100(6):1285–302. https://doi.org/10.1016/j.mcna.2016.06.009.CrossRefPubMed

Acosta-Montano P, Garcia-Gonzalez V. Effects of dietary fatty acids in pancreatic beta cell metabolism, implications in homeostasis. Nutrients. 2018;10(4). https://doi.org/10.3390/nu10040393.CrossRef

Muley A, Muley P, Shah M. ALA, fatty fish or marine n-3 fatty acids for preventing DM?: a systematic review and meta-analysis. Curr Diabetes Rev. 2014;10(3):158–65.CrossRef

Wallin A, Di Giuseppe D, Orsini N, Patel PS, Forouhi NG, Wolk A. Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care. 2012;35(4):918–29. https://doi.org/10.2337/dc11-1631.CrossRefPubMedPubMedCentral

Wu JH, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, et al. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr. 2012;107(Suppl 2):S214–27. https://doi.org/10.1017/S0007114512001602.CrossRefPubMedPubMedCentral

10.

• Zheng JS, Huang T, Yang J, Fu YQ, Li D. Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS One. 2012;7(9):e44525. https://doi.org/10.1371/journal.pone.0044525 This systematic review and meta-analysis of prospective cohort studies examined the associations of fish and n -3 polyunsaturated fatty acid intake with type 2 diabetes risk. The pooled analysis allowed for differences between Asian and Western cohorts to emerge.CrossRefPubMedPubMedCentral

11.

Zhou Y, Tian C, Jia C. Association of fish and n-3 fatty acid intake with the risk of type 2 diabetes: a meta-analysis of prospective studies. Br J Nutr. 2012;108(3):408–17. https://doi.org/10.1017/S0007114512002036.CrossRefPubMed

12.

Kaushik M, Mozaffarian D, Spiegelman D, Manson JE, Willett WC, Hu FB. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr. 2009;90(3):613–20. https://doi.org/10.3945/ajcn.2008.27424.CrossRefPubMedPubMedCentral

13.

Brostow DP, Odegaard AO, Koh WP, Duval S, Gross MD, Yuan JM, et al. Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2011;94(2):520–6. https://doi.org/10.3945/ajcn.110.009357.CrossRefPubMedPubMedCentral

14.

Djousse L, Gaziano JM, Buring JE, Lee IM. Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr. 2011;93(1):143–50. https://doi.org/10.3945/ajcn.110.005603.CrossRefPubMed

15.

Margolis KL, Wei F, de Boer IH, Howard BV, Liu S, Manson JE, et al. A diet high in low-fat dairy products lowers diabetes risk in postmenopausal women. J Nutr. 2011;141(11):1969–74. https://doi.org/10.3945/jn.111.143339.CrossRefPubMedPubMedCentral

16.

Villegas R, Xiang YB, Elasy T, Li HL, Yang G, Cai H, et al. Fish, shellfish, and long-chain n-3 fatty acid consumption and risk of incident type 2 diabetes in middle-aged Chinese men and women. Am J Clin Nutr. 2011;94(2):543–51. https://doi.org/10.3945/ajcn.111.013193.CrossRefPubMedPubMedCentral

17.

Alhazmi A, Stojanovski E, McEvoy M, Garg ML. Macronutrient intake and type 2 diabetes risk in middle-aged Australian women. Results from the Australian longitudinal study on Women’s health. Public Health Nutr. 2014;17(7):1587–94. https://doi.org/10.1017/S1368980013001870.CrossRefPubMed

18.

Louie JC, Flood VM, Rangan AM, Burlutsky G, Gill TP, Gopinath B, et al. Higher regular fat dairy consumption is associated with lower incidence of metabolic syndrome but not type 2 diabetes. Nutr Metab Cardiovasc Dis. 2013;23(9):816–21. https://doi.org/10.1016/j.numecd.2012.08.004.CrossRefPubMed

19.

Ericson U, Hellstrand S, Brunkwall L, Schulz CA, Sonestedt E, Wallstrom P, et al. Food sources of fat may clarify the inconsistent role of dietary fat intake for incidence of type 2 diabetes. Am J Clin Nutr. 2015;101(5):1065–80. https://doi.org/10.3945/ajcn.114.103010.CrossRefPubMed

20.

Guasch-Ferre M, Hruby A, Salas-Salvado J, Martinez-Gonzalez MA, Sun Q, Willett WC, et al. Olive oil consumption and risk of type 2 diabetes in US women. Am J Clin Nutr. 2015;102(2):479–86. https://doi.org/10.3945/ajcn.115.112029.CrossRefPubMedPubMedCentral

21.

Guasch-Ferre M, Becerra-Tomas N, Ruiz-Canela M, Corella D, Schroder H, Estruch R, et al. Total and subtypes of dietary fat intake and risk of type 2 diabetes mellitus in the Prevencion con Dieta Mediterranea (PREDIMED) study. Am J Clin Nutr. 2017;105(3):723–35. https://doi.org/10.3945/ajcn.116.142034.CrossRefPubMed

22.

Patel PS, Sharp SJ, Jansen E, Luben RN, Khaw KT, Wareham NJ, et al. Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr. 2010;92(5):1214–22. https://doi.org/10.3945/ajcn.2010.29182.CrossRefPubMed

23.

•• Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, et al. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med. 2010;153(12):790–9. https://doi.org/10.7326/0003-4819-153-12-201012210-00005 This analysis from the Cardiovascular Health Study investigated whether circulating trans-palmitoleic acid was independently related to lower metabloc risk and incident type 2 diabetes. The use of fatty acid biomarkers in combination with self-reported dietary data revealed a potentially unique role of dairy fat in reduced risk for type 2 diabetes.CrossRefPubMedPubMedCentral

24.

Djousse L, Biggs ML, Lemaitre RN, King IB, Song X, Ix JH, et al. Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr. 2011;94(2):527–33. https://doi.org/10.3945/ajcn.111.013334.CrossRefPubMedPubMedCentral

25.

Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Hotamisligil G, Tsai MY, et al. Trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the multi-ethnic study of atherosclerosis (MESA). Am J Clin Nutr. 2013;97(4):854–61. https://doi.org/10.3945/ajcn.112.045468.CrossRefPubMedPubMedCentral

26.

Mahendran Y, Cederberg H, Vangipurapu J, Kangas AJ, Soininen P, Kuusisto J, et al. Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men. Diabetes Care. 2013;36(11):3732–8. https://doi.org/10.2337/dc13-0800.CrossRefPubMedPubMedCentral

27.

Santaren ID, Watkins SM, Liese AD, Wagenknecht LE, Rewers MJ, Haffner SM, et al. Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders. Am J Clin Nutr. 2014;100(6):1532–40. https://doi.org/10.3945/ajcn.114.092544.CrossRefPubMedPubMedCentral

28.

Mahendran Y, Agren J, Uusitupa M, Cederberg H, Vangipurapu J, Stancakova A, et al. Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. Am J Clin Nutr. 2014;99(1):79–85. https://doi.org/10.3945/ajcn.113.069740.CrossRefPubMed

29.

Virtanen JK, Mursu J, Voutilainen S, Uusitupa M, Tuomainen TP. Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the Kuopio ischemic heart disease risk factor study. Diabetes Care. 2014;37(1):189–96. https://doi.org/10.2337/dc13-1504.CrossRefPubMed

30.

Lemaitre RN, Fretts AM, Sitlani CM, Biggs ML, Mukamal K, King IB, et al. Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study. Am J Clin Nutr. 2015;101(5):1047–54. https://doi.org/10.3945/ajcn.114.101857.CrossRefPubMedPubMedCentral

31.

Ma W, Wu JH, Wang Q, Lemaitre RN, Mukamal KJ, Djousse L, et al. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study. Am J Clin Nutr. 2015;101(1):153–63. https://doi.org/10.3945/ajcn.114.092601.CrossRefPubMed

32.

Lankinen MA, Stancakova A, Uusitupa M, Agren J, Pihlajamaki J, Kuusisto J, et al. Plasma fatty acids as predictors of glycaemia and type 2 diabetes. Diabetologia. 2015;58(11):2533–44. https://doi.org/10.1007/s00125-015-3730-5.CrossRefPubMed

33.

Steffen BT, Steffen LM, Zhou X, Ouyang P, Weir NL, Tsai MY. n-3 Fatty acids attenuate the risk of diabetes associated with elevated serum nonesterified fatty acids: the multi-ethnic study of atherosclerosis. Diabetes Care. 2015;38(4):575–80. https://doi.org/10.2337/dc14-1919.CrossRefPubMedPubMedCentral

34.

Takkunen MJ, Schwab US, de Mello VD, Eriksson JG, Lindstrom J, Tuomilehto J, et al. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study. Eur J Nutr. 2016;55(3):967–79. https://doi.org/10.1007/s00394-015-0911-4.CrossRefPubMed

35.

Yakoob MY, Shi P, Willett WC, Rexrode KM, Campos H, Orav EJ, et al. Circulating biomarkers of dairy fat and risk of incident diabetes mellitus among men and women in the United States in two large prospective cohorts. Circulation. 2016;133(17):1645–54. https://doi.org/10.1161/CIRCULATIONAHA.115.018410.CrossRefPubMedPubMedCentral

36.

Yary T, Voutilainen S, Tuomainen TP, Ruusunen A, Nurmi T, Virtanen JK. Serum n-6 polyunsaturated fatty acids, Delta5- and Delta6-desaturase activities, and risk of incident type 2 diabetes in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. 2016;103(5):1337–43. https://doi.org/10.3945/ajcn.115.128629.CrossRefPubMed

37.

Howard BV, Aragaki AK, Tinker LF, Allison M, Hingle MD, Johnson KC, et al. A low-fat dietary pattern and diabetes: a secondary analysis from the Women’s Health Initiative dietary modification trial. Diabetes Care. 2018;41(4):680–7. https://doi.org/10.2337/dc17-0534.CrossRefPubMed

38.

United States. Department of Health and Human Services., United States. Department of Agriculture., United States. Dietary Guidelines Advisory Committee. Dietary guidelines for Americans, 2015-2020. Eighth edition. ed. Washington, D.C.: U.S. Department of Health and Human Services and U.S. Department of Agriculture; 2015.

39.

de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ. 2015;351:h3978. https://doi.org/10.1136/bmj.h3978.CrossRefPubMedPubMedCentral

40.

Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, et al. Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr. 2010;92(6):1350–8. https://doi.org/10.3945/ajcn.110.003970.CrossRefPubMedPubMedCentral

41.

• Ratnayake WM. Concerns about the use of 15:0, 17:0, and trans-16:1n-7 as biomarkers of dairy fat intake in recent observational studies that suggest beneficial effects of dairy food on incidence of diabetes and stroke. Am J Clin Nutr. 2015;101(5):1102–3. https://doi.org/10.3945/ajcn.114.105379 This Letter to the Editor eloquently outlines the potential pitfalls of relying too heavily on biomarker data to draw definitive conclusions about diet and health. It is an important commentary that can be extrapolated to much of the literature in nutrition research.CrossRefPubMedPubMedCentral

42.

Due A, Larsen TM, Mu H, Hermansen K, Stender S, Astrup A. Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial. Am J Clin Nutr. 2008;88(5):1232–41. https://doi.org/10.3945/ajcn.2007.25695.CrossRefPubMed

43.

Gadgil MD, Appel LJ, Yeung E, Anderson CA, Sacks FM, Miller ER 3rd. The effects of carbohydrate, unsaturated fat, and protein intake on measures of insulin sensitivity: results from the OmniHeart trial. Diabetes Care. 2013;36(5):1132–7. https://doi.org/10.2337/dc12-0869.CrossRefPubMedPubMedCentral

44.

Tinker LF, Bonds DE, Margolis KL, Manson JE, Howard BV, Larson J, et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women’s Health Initiative randomized controlled dietary modification trial. Arch Intern Med. 2008;168(14):1500–11. https://doi.org/10.1001/archinte.168.14.1500.CrossRefPubMed

Title: Dietary Fat and Risk for Type 2 Diabetes: a Review of Recent Research
Author: Beth H. Rice Bradley
Publication date: 01-12-2018
Publisher: Springer US
Published in: Current Nutrition Reports / Issue 4/2018
Electronic ISSN: 2161-3311
DOI: https://doi.org/10.1007/s13668-018-0244-z

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2018

Intergenerational Effects of Health Issues Among Women of Childbearing Age: a Review of the Recent Literature

Dairy Consumption and Cardiometabolic Diseases: Systematic Review and Updated Meta-Analyses of Prospective Cohort Studies

Sugar-Sweetened Beverages and Child Health: Implications for Policy

Maternal Predictors of Child Dietary Behaviors and Weight Status

Weight Regain After Bariatric Surgery: Prevalence, Etiology, and Treatment

Fad Diets: Hype or Hope?

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage